Brucella canis treatment debate spotlights ethics, risk, and welfare
Bottom line
A new commentary from Scott Weese on Worms & Germs argues against a one-size-fits-all approach to dogs that test positive for Brucella canis, especially the idea that every case should automatically end in euthanasia or lifelong isolation. Weese’s focus is the ethics of treatment: not denying the zoonotic risk, but questioning whether blanket rules reflect the full clinical, public health, and welfare picture. That debate sits within a difficult reality: CDC says B. canis infection in dogs is considered non-curable, and dogs may continue shedding even if treatment is attempted. Cornell likewise notes there’s no official or completely effective treatment protocol, relapses are common, and some states require reporting, neutering, or euthanasia. (cdc.gov)
Why it matters: For veterinarians, this is a welfare-and-risk communication problem as much as an infectious disease problem. B. canis can infect people, especially those exposed to reproductive tissues and fluids, yet human disease appears uncommon and likely underdiagnosed. Diagnostic uncertainty, intermittent shedding, state-by-state reporting rules, antimicrobial stewardship concerns, and the emotional weight for pet parents all make case management highly individualized. Existing public health guidance emphasizes education, PPE, serial monitoring, and limiting exposure if treatment is pursued, rather than assuming cure is achievable. (cdc.gov)
What to watch: Expect continued debate over when treatment is ethically defensible, especially as more jurisdictions refine reporting expectations and as veterinary groups push for clearer, risk-based management guidance. (cdc.gov)
Scott Weese is pressing on one of small animal medicine’s hardest gray zones: what veterinarians should do when a dog is diagnosed with Brucella canis. In a new Worms & Germs post on the ethics of treatment, Weese argues he’s not comfortable with a blanket “euthanize or isolate forever” stance, even while acknowledging the organism’s zoonotic potential and the real limits of treatment. His position doesn’t minimize the disease. Instead, it reframes the question around proportionality, context, and whether every positive dog should be managed as if the risk profile is identical. (cdc.gov)
That tension has been building for years. B. canis is a dog-adapted Brucella species associated most often with reproductive disease, but it can also be linked to diskospondylitis and other chronic problems. The organism is difficult to eliminate, diagnostic testing has important limitations, and infected dogs may be asymptomatic or intermittently bacteremic, which complicates both case finding and follow-up. A 2018 CDC review described treatment after reproductive disease as usually unsuccessful when antimicrobials are used alone, and noted that management discussions often center on sterilization, antimicrobial therapy, repeat testing, or euthanasia. (wwwnc.cdc.gov)
Current guidance still leans cautious. CDC tells veterinarians that B. canis infection in dogs is considered non-curable and that, if pet parents choose treatment, they should be told the dog may continue to shed bacteria. The agency recommends exposure precautions, separation from other people and animals, and serial testing to monitor persistence or relapse. Cornell’s veterinary guidance is similar: there is no completely effective treatment protocol, relapses are common, and some states treat the disease as reportable, with management requirements that can include neutering or euthanasia. The MSD Veterinary Manual also says no treatment is known to reliably eliminate infection or prevent recrudescence, which is why treatment is often discouraged. (cdc.gov)
The public health backdrop explains why many regulators and clinicians remain uneasy. In a CDC/MMWR report from South Carolina, a pregnant stray dog with confirmed B. canis exposed 17 people and five animals across two households and a veterinary clinic before diagnosis was confirmed. No secondary cases were identified, but the investigation required coordinated work across veterinary, laboratory, and public health teams, and three people with high-risk exposure received post-exposure prophylaxis. CDC’s conclusion was straightforward: veterinarians need a high index of suspicion in dogs with abortion or infertility, and risk communication is essential. (cdc.gov)
At the same time, the human risk is not simple to quantify. Weese wrote in April 2026 that a recent scoping review found only 68 published human B. canis infections, while also stressing that underdiagnosis is likely because human illness is nonspecific and approved serologic tests for people are lacking. That lines up with CDC’s warning that no approved serologic test exists for human diagnosis of B. canis, making surveillance and reassurance harder. In other words, the risk is real, but the evidence base is thin enough that both overreaction and underreaction are possible. (cdc.gov)
Why it matters: For veterinary professionals, this is ultimately about how to balance animal welfare, occupational safety, client counseling, and antimicrobial stewardship when there is no clean answer. A rigid euthanasia-first approach may conflict with welfare goals in clinically stable dogs, especially when pet parents can comply with sterilization, hygiene, confinement, and long-term monitoring. But a casual treatment-first approach risks exposing clinic staff, households, and other animals to a pathogen that may persist despite months of therapy. The ethical center of gravity is shifting toward informed, case-specific decision-making, but that only works if practices have clear protocols for PPE, diagnostics, state reporting, recordkeeping, and communication. (cdc.gov)
Professional and industry groups are also signaling that this needs structured management, not improvisation. The Society for Theriogenology and American College of Theriogenologists say B. canis is a threat to breeding and pet dogs, their pet parents, and immunocompromised people in the community. Meanwhile, older and newer reviews alike point to the same unresolved issues: weak surveillance, uneven regulation, imperfect diagnostics, and no proven curative therapy. That leaves front-line veterinarians carrying much of the ethical burden in exam rooms and isolation wards. (therio.org)
What to watch: The next phase is likely to focus less on whether B. canis is serious, and more on whether the profession can standardize risk-based pathways for treatment, monitoring, and client education across states, especially for rescue, imported, and breeding dogs. (wwwnc.cdc.gov)